Cargando…
Multi ‘Omics Analysis of Intestinal Tissue in Ankylosing Spondylitis Identifies Alterations in the Tryptophan Metabolism Pathway
Intestinal microbial dysbiosis, intestinal inflammation, and Th17 immunity are all linked to the pathophysiology of spondyloarthritis (SpA); however, the mechanisms linking them remain unknown. One potential hypothesis suggests that the dysbiotic gut microbiome as a whole produces metabolites that i...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7966505/ https://www.ncbi.nlm.nih.gov/pubmed/33746944 http://dx.doi.org/10.3389/fimmu.2021.587119 |
_version_ | 1783665699480141824 |
---|---|
author | Berlinberg, Adam J. Regner, Emilie H. Stahly, Andrew Brar, Ana Reisz, Julie A. Gerich, Mark E. Fennimore, Blair P. Scott, Frank I. Freeman, Alison E. Kuhn, Kristine A. |
author_facet | Berlinberg, Adam J. Regner, Emilie H. Stahly, Andrew Brar, Ana Reisz, Julie A. Gerich, Mark E. Fennimore, Blair P. Scott, Frank I. Freeman, Alison E. Kuhn, Kristine A. |
author_sort | Berlinberg, Adam J. |
collection | PubMed |
description | Intestinal microbial dysbiosis, intestinal inflammation, and Th17 immunity are all linked to the pathophysiology of spondyloarthritis (SpA); however, the mechanisms linking them remain unknown. One potential hypothesis suggests that the dysbiotic gut microbiome as a whole produces metabolites that influence human immune cells. To identify potential disease-relevant, microbiome-produced metabolites, we performed metabolomics screening and shotgun metagenomics on paired colon biopsies and fecal samples, respectively, from subjects with axial SpA (axSpA, N=21), Crohn’s disease (CD, N=27), and Crohn’s-axSpA overlap (CD-axSpA, N=12), as well as controls (HC, N=24). Using LC-MS based metabolomics of 4 non-inflamed pinch biopsies of the distal colon from subjects, we identified significant alterations in tryptophan pathway metabolites, including an expansion of indole-3-acetate (IAA) in axSpA and CD-axSpA compared to HC and CD and indole-3-acetaldehyde (I3Ald) in axSpA and CD-axSpA but not CD compared to HC, suggesting possible specificity to the development of axSpA. We then performed shotgun metagenomics of fecal samples to characterize gut microbial dysbiosis across these disease states. In spite of no significant differences in alpha-diversity among the 4 groups, our results confirmed differences in gene abundances of numerous enzymes involved in tryptophan metabolism. Specifically, gene abundance of indolepyruvate decarboxylase, which generates IAA and I3Ald, was significantly elevated in individuals with axSpA while gene abundances in HC demonstrated a propensity towards tryptophan synthesis. Such genetic changes were not observed in CD, again suggesting disease specificity for axSpA. Given the emerging role of tryptophan and its metabolites in immune function, altogether these data indicate that tryptophan metabolism into I3Ald and then IAA is one mechanism by which the gut microbiome potentially influences the development of axSpA. |
format | Online Article Text |
id | pubmed-7966505 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-79665052021-03-18 Multi ‘Omics Analysis of Intestinal Tissue in Ankylosing Spondylitis Identifies Alterations in the Tryptophan Metabolism Pathway Berlinberg, Adam J. Regner, Emilie H. Stahly, Andrew Brar, Ana Reisz, Julie A. Gerich, Mark E. Fennimore, Blair P. Scott, Frank I. Freeman, Alison E. Kuhn, Kristine A. Front Immunol Immunology Intestinal microbial dysbiosis, intestinal inflammation, and Th17 immunity are all linked to the pathophysiology of spondyloarthritis (SpA); however, the mechanisms linking them remain unknown. One potential hypothesis suggests that the dysbiotic gut microbiome as a whole produces metabolites that influence human immune cells. To identify potential disease-relevant, microbiome-produced metabolites, we performed metabolomics screening and shotgun metagenomics on paired colon biopsies and fecal samples, respectively, from subjects with axial SpA (axSpA, N=21), Crohn’s disease (CD, N=27), and Crohn’s-axSpA overlap (CD-axSpA, N=12), as well as controls (HC, N=24). Using LC-MS based metabolomics of 4 non-inflamed pinch biopsies of the distal colon from subjects, we identified significant alterations in tryptophan pathway metabolites, including an expansion of indole-3-acetate (IAA) in axSpA and CD-axSpA compared to HC and CD and indole-3-acetaldehyde (I3Ald) in axSpA and CD-axSpA but not CD compared to HC, suggesting possible specificity to the development of axSpA. We then performed shotgun metagenomics of fecal samples to characterize gut microbial dysbiosis across these disease states. In spite of no significant differences in alpha-diversity among the 4 groups, our results confirmed differences in gene abundances of numerous enzymes involved in tryptophan metabolism. Specifically, gene abundance of indolepyruvate decarboxylase, which generates IAA and I3Ald, was significantly elevated in individuals with axSpA while gene abundances in HC demonstrated a propensity towards tryptophan synthesis. Such genetic changes were not observed in CD, again suggesting disease specificity for axSpA. Given the emerging role of tryptophan and its metabolites in immune function, altogether these data indicate that tryptophan metabolism into I3Ald and then IAA is one mechanism by which the gut microbiome potentially influences the development of axSpA. Frontiers Media S.A. 2021-03-03 /pmc/articles/PMC7966505/ /pubmed/33746944 http://dx.doi.org/10.3389/fimmu.2021.587119 Text en Copyright © 2021 Berlinberg, Regner, Stahly, Brar, Reisz, Gerich, Fennimore, Scott, Freeman and Kuhn http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Berlinberg, Adam J. Regner, Emilie H. Stahly, Andrew Brar, Ana Reisz, Julie A. Gerich, Mark E. Fennimore, Blair P. Scott, Frank I. Freeman, Alison E. Kuhn, Kristine A. Multi ‘Omics Analysis of Intestinal Tissue in Ankylosing Spondylitis Identifies Alterations in the Tryptophan Metabolism Pathway |
title | Multi ‘Omics Analysis of Intestinal Tissue in Ankylosing Spondylitis Identifies Alterations in the Tryptophan Metabolism Pathway |
title_full | Multi ‘Omics Analysis of Intestinal Tissue in Ankylosing Spondylitis Identifies Alterations in the Tryptophan Metabolism Pathway |
title_fullStr | Multi ‘Omics Analysis of Intestinal Tissue in Ankylosing Spondylitis Identifies Alterations in the Tryptophan Metabolism Pathway |
title_full_unstemmed | Multi ‘Omics Analysis of Intestinal Tissue in Ankylosing Spondylitis Identifies Alterations in the Tryptophan Metabolism Pathway |
title_short | Multi ‘Omics Analysis of Intestinal Tissue in Ankylosing Spondylitis Identifies Alterations in the Tryptophan Metabolism Pathway |
title_sort | multi ‘omics analysis of intestinal tissue in ankylosing spondylitis identifies alterations in the tryptophan metabolism pathway |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7966505/ https://www.ncbi.nlm.nih.gov/pubmed/33746944 http://dx.doi.org/10.3389/fimmu.2021.587119 |
work_keys_str_mv | AT berlinbergadamj multiomicsanalysisofintestinaltissueinankylosingspondylitisidentifiesalterationsinthetryptophanmetabolismpathway AT regneremilieh multiomicsanalysisofintestinaltissueinankylosingspondylitisidentifiesalterationsinthetryptophanmetabolismpathway AT stahlyandrew multiomicsanalysisofintestinaltissueinankylosingspondylitisidentifiesalterationsinthetryptophanmetabolismpathway AT brarana multiomicsanalysisofintestinaltissueinankylosingspondylitisidentifiesalterationsinthetryptophanmetabolismpathway AT reiszjuliea multiomicsanalysisofintestinaltissueinankylosingspondylitisidentifiesalterationsinthetryptophanmetabolismpathway AT gerichmarke multiomicsanalysisofintestinaltissueinankylosingspondylitisidentifiesalterationsinthetryptophanmetabolismpathway AT fennimoreblairp multiomicsanalysisofintestinaltissueinankylosingspondylitisidentifiesalterationsinthetryptophanmetabolismpathway AT scottfranki multiomicsanalysisofintestinaltissueinankylosingspondylitisidentifiesalterationsinthetryptophanmetabolismpathway AT freemanalisone multiomicsanalysisofintestinaltissueinankylosingspondylitisidentifiesalterationsinthetryptophanmetabolismpathway AT kuhnkristinea multiomicsanalysisofintestinaltissueinankylosingspondylitisidentifiesalterationsinthetryptophanmetabolismpathway |